Home Statera Biopharma

Statera Biopharma

In operation
IPO
Developer of Novel Immunotherapies
Basic
Enterprise Profile

Basic Information

Statera Biopharma (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company dedicated to developing novel immunotherapies for cancer, infectious diseases, and autoimmune disorders, with a focus on drug repurposing. These therapies utilize their patented treatments, emphasizing the activation and balancing of the human immune system.
Statera Biopharma, Inc.
Colorado,United States of America
15~50 people
January 01, 2014
info@cytocom.com

Enterprise Profile

Industrial Sector
New Drug Development Immune Cell Therapy
Technology
Biotechnology
Concept
Tumor Immune System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs